Remarkably, in some types of cancer, including multiple myeloma, mesenchymal stromal cells in the tumor milieu have been found to be involved in cancer resistance to CAR T-cell therapies by upregulating survivin [101], which has been shown to serve as an anti-apoptotic factor in a variety of pathological conditions [261, 262]. Here, BIRC5 is linked to AL amyloidosis.